Post by
blackice9090 on Oct 11, 2017 3:17am
Weather the Storm
What investors need to remember is you invested in a pre revenue pharmaceutical company. That means you are investing in this companies potential as a growth investor. You should collectively stop focusing so much on revenues because even a good trailing 12 month stream will not necessarily indicate the future of the company. Focus on the fundamentals that brought us to this stock in the first place (management team, CSO, low burn rates, transparency). TBH even if modest profits are presented, the company has announced it will be using revenues to fund the meat and potatoes which are the development side of things anyways. They will be used for SUSTAINANCE only. In other words, don't expect to get rich off their gum sales. You will see your revenues with PPP001, Dronabinol, and anything else the DIN will provide us. True, you aren't cashing in on the strengths of the rest of the MJ market now, but you also weren't absorbing any of the weaknesses that recently came to pass. We are in a different category and you will know this difference soon enough. And one more thing, TBP knows what it is doing when it comes to Branding. These conference announcements are pivotal when it comes to establishing a brand and they should be commended on how well they have done so far in a market with high barriers to entry. Av8tor needs to get his business mind right.
Comment by
4evergreen on Oct 11, 2017 10:11am
You nailed it. Well said, thank you.